STOCK TITAN

Vertical Aerospace gets six-month NYSE cure period

EVTL's ordinary shares will continue trading during the six-month cure period, subject to the NYSE's other continued listing requirements.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
6-K

Rhea-AI Filing Summary

Vertical Aerospace Ltd. (EVTL) received a New York Stock Exchange notice on September 9, 2026, stating that its ordinary shares’ average closing price was below $1.00 per share over 30 consecutive trading days. The company told the NYSE it intends to cure the deficiency.

Vertical can regain compliance during the six-month cure period following receipt if, on the last trading day of any calendar month, its shares close at least $1.00 and average at least $1.00 over the 30 trading-day period ending that day. Its ordinary shares will continue trading during the cure period, subject to other continued listing requirements. The company said the notice has no immediate effect on the listing and is not anticipated to affect ongoing operations.

0 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • None.

Negative

  • Major pointNYSE average closing price below $1.00 over 30 trading days.
NYSE minimum average closing price $1.00 per share Required over 30 consecutive trading days
Initial price measurement period 30 consecutive trading days Period underlying the NYSE notice
Cure period Six months Following receipt of the NYSE notice
Valo pre-orders Approximately 1,500 pre-orders Company-reported orders across four continents
Valo passenger capacity 4 passengers Piloted electric vertical take-off and landing aircraft
Customer locations Four continents Locations of Valo customers
continued listing standards regulatory
"NYSE continued listing standards"
Ongoing rules a stock exchange requires a listed company to meet to keep its shares trading publicly, such as minimum share price, market value, timely financial reports, and governance practices. Think of it as a membership checklist for a club: falling short can lead to warnings or removal from the exchange, which can sharply reduce liquidity, investor confidence, and a stock’s value. Investors watch these standards to gauge regulatory risk and the stability of their holdings.
cure period regulatory
"within a six-month cure period"
A cure period is a set amount of time given to a borrower, counterparty, or contracting party to fix a missed payment, breach, or other problem before more serious consequences—like penalties, higher interest, or contract termination—kick in. For investors, it matters because it creates a short grace window that can prevent immediate losses and influence the timing and likelihood of recovery; think of it like a few extra days to pay a bill before a service is cut off.
average closing share price market
"average closing share price of at least $1.00"
The average closing share price is the arithmetic mean of a stock’s end-of-day trading prices over a specified period (for example, a week, month, or year). It gives investors a single, smoothed number that represents where the market has settled on the stock most days, much like an average temperature summarizes daily highs and lows. Investors use it to spot trends, compare valuation over time, and reduce the noise from day-to-day swings.
eVTOL technical
"Electric Vertical Take-Off and Landing (eVTOL) aircraft"
eVTOL stands for "electric vertical takeoff and landing" aircraft, which are small, electric-powered vehicles capable of taking off and landing vertically like a helicopter. They are designed to provide quick, on-demand transportation within cities or between locations, potentially transforming urban mobility. For investors, eVTOLs represent a growing segment of innovative transportation technology with potential for significant market impact and future growth.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Why did EVTL receive an NYSE continued-listing notice?

The NYSE notified Vertical Aerospace on September 9, 2026, that its ordinary shares’ average closing price was below $1.00 over 30 consecutive trading days.

What must EVTL do to regain NYSE compliance?

On the last trading day of any calendar month during the six-month cure period, its shares must have both a closing price of at least $1.00 and an average closing price of at least $1.00 over the 30 trading-day period ending that day.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO SECTION 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October 2026

 

Commission File Number: 001-41169

 

 

Vertical Aerospace Ltd.

(Exact Name of Registrant as Specified in Its Charter)

 

 

Unit 1 Camwal Court, Chapel Street

Bristol BS2 0UW

United Kingdom

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F   x            Form 40-F   ¨

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On September 9, 2026, Vertical Aerospace Ltd. (the “Company”) received written notice from the New York Stock Exchange (the “NYSE”) that it is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of the Company’s ordinary shares was less than $1.00 per share over a consecutive 30 trading-day period (the “Notice”).

 

In accordance with applicable NYSE rules, the Company has notified the NYSE that it intends to cure the stock price deficiency and return to compliance with the NYSE continued listing standards. The Company can regain compliance at any time within a six-month cure period following its receipt of the NYSE notice if, on the last trading day of any calendar month during such cure period, the Company has both: (i) a closing share price of at least $1.00 and (ii) an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month. The Company intends to remain listed on the NYSE and will consider available options for regaining compliance.

 

The Notice has no immediate impact on the listing of the Company’s ordinary shares, which will continue to be listed on the NYSE during such cure period and is not anticipated to impact the ongoing business operations of the Company.

 

As required by Section 802.01C of the NYSE Listed Company Manual, the Company issued a press release on October 2, 2026, announcing that it had received the notice of noncompliance with the NYSE’s continued listing standards. A copy of the press release is furnished herewith as Exhibit 99.1.

 

Forward-Looking Statements

 

This Report of Foreign Private Issuer on Form 6-K (the “Form 6-K”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this Form 6-K that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the value of the Company’s ordinary shares, the Company’s ability to regain compliance with the NYSE continued listing standards on the timeline required, the Company’s continued trading of its ordinary shares on the NYSE, and the anticipated impact of the Notice on the Company’s operations, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate,” “will,” “aim,” “potential,” “continue,” “is/are likely to” and similar statements of a future or forward-looking nature. These forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the important factors discussed under the caption “Risk Factors” in the Company's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on March 24, 2026, as such factors may be updated from time to time in the Company’s other filings with the SEC. Any forward-looking statements contained in this Form 6-K speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. The Company disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this Form 6-K, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

 

 

 

 

INCORPORATION BY REFERENCE

 

The information included in this Report on Form 6-K (excluding Exhibit 99.1) is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-270756, File No. 333-284763, File No. 333-287207, File No. 333-292448, File No. 333-295988, File No. 333-297060 and File No. 333-298605) (including any prospectuses forming a part of such registration statements) and to be a part thereof from the date on which this Report on Form 6-K is filed, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

 

 

EXHIBIT INDEX

 

Exhibit
No.
  Description
     
99.1   Press release of Vertical Aerospace Ltd. dated October 2, 2026

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Vertical Aerospace Ltd.
     
Date: October 2, 2026 By: /s/ Stuart Simpson
    Stuart Simpson
    Chief Executive Officer

 

 

 

 

Exhibit 99.1

 

Vertical Aerospace Receives Continued Listing Standard Notice from NYSE

 

New York, US, London, UK – October 2, 2026 – Vertical Aerospace (“Vertical” or the “Company”) [NYSE: EVTL], a global aerospace and technology company pioneering electric vertical take-off and landing (“eVTOL”) aircraft, today announced that it received a notice from the New York Stock Exchange (the “NYSE”) on September 9, 2026, indicating that the Company is not currently in compliance with the NYSE continued listing standard requiring a minimum average closing price for its ordinary shares of $1.00 over the preceding 30 consecutive trading days.

 

Vertical has notified the NYSE that it intends to regain compliance with the NYSE’s continued listing standards and is considering all available options to do so that are in the best interests of Vertical and its shareholders. Vertical can regain compliance with the NYSE’s continued listing requirements at any time during a six-month cure period if, on the last trading day of any calendar month during the cure period, the ordinary shares have a closing share price of at least $1.00 and an average closing share price of at least $1.00 over the 30 trading-day period ending on the last trading day of that month.

 

The NYSE notice has no immediate effect on the continued listing of Vertical’s ordinary shares on the NYSE and is not anticipated to have any impact on Vertical’s ongoing business operations. Under the NYSE’s rules, Vertical’s ordinary shares will continue to be listed and will trade on the NYSE, subject to compliance with other continued listing requirements.

 

About Vertical Aerospace

 

Vertical Aerospace is a global aerospace and technology company pioneering electric aviation. Vertical is creating a safer, cleaner, and quieter way to travel. Valo is a piloted, four-passenger, Electric Vertical Take-Off and Landing (eVTOL) aircraft, with zero operating emissions. Vertical is also developing a hybrid-electric variant, offering increased range and mission flexibility to meet the evolving needs of the advanced air mobility market.

 

Vertical combines partnerships with leading aerospace companies, including Honeywell Aerospace, Syensqo and Sonaca, with its own proprietary battery and propeller technology to develop the world’s most advanced and safest eVTOL.

 

Vertical has c.1,500 pre-orders of Valo, with customers across four continents, including American Airlines, Avolon, Bristow, GOL and Japan Airlines. Certain customer obligations are expected to be fulfilled via third-party agreements. Headquartered in Bristol, UK, Vertical’s experienced leadership team comes from top-tier aerospace and automotive companies such as Rolls-Royce, Airbus, GM, and Leonardo. Together, they have previously certified and supported over 30 different civil and military aircraft and propulsion systems.

 

 

 

 

Forward-Looking Statements

 

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any express or implied statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements, including, without limitation, statements regarding the value of the Company’s ordinary shares, the Company’s ability to regain compliance with the NYSE continued listing standards on the timeline required, the Company’s continued trading of its ordinary shares on the NYSE, and the anticipated impact of the notice from the NYSE on the Company’s operations, as well as statements that include the words “expect,” “intend,” “plan,” “believe,” “project,” “forecast,” “estimate,” “may,” “should,” “anticipate,” “will,” “aim,” “potential,” “continue,” “is/are likely to” and similar statements of a future or forward-looking nature. These forward-looking statements reflect our current views with respect to future events and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the important factors discussed under the caption “Risk Factors” in Vertical’s Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (“SEC”) on March 24, 2026, as such factors may be updated from time to time in Vertical’s other filings with the SEC. Any forward-looking statements contained in this Form 6-K speak only as of the date hereof and accordingly undue reliance should not be placed on such statements. Vertical disclaims any obligation or undertaking to update or revise any forward-looking statements contained in this Form 6-K, whether as a result of new information, future events or otherwise, other than to the extent required by applicable law.

 

For more information:

 

Vertical Aerospace Media:
Justin Bates, Head of Communications
justin.bates@vertical-aerospace.com
+44 7878 357 463

 

Vertical Aerospace Investor Relations:
Gillian Levine, Investor Relations Lead
gillian.levine@vertical-aerospace.com
+1 248 470 8732

 

 

 

Filing Exhibits & Attachments

1 document

Keep reading